Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Spectrometry Based Cutoffs for Cortisol and 17-OH-progesterone
NCT02818660Completed
- Sponsor
- Haukeland University Hospital
- Start
- May 2016
- Primary completion
- Dec 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tetracosactide hexaacetate in adrenal insufficiency (AI), sponsored by Haukeland University Hospital. Primary endpoint: Cutoff level for serum cortisol after stimulation at 2 year. Started May 2016; status: completed.
02
Drugs
tetracosactide hexaacetate
03
Conditions
adrenal insufficiency (AI)
Beyond the preview
Go deeper on NCT02818660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02818660.